-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to fully grasp the progress of clinical trials for new drug registration in China, use information technology to improve drug supervision capabilities, disclose clinical trial progress information in a timely manner, and provide reference for new drug research and development, resource allocation, and drug review and approval, the Center for Drug Evaluation is based on the registration and approval of drug clinical tria.
This annual report is mainly based on the information of drug clinical trials registered in 2021, including drug types, varieties and target characteristics, indications, sponsor types, registration classification, trial classification, trial staging, special population trials, and clinical trial team leader uni.
Attachment: Annual Report on Progress of Clinical Trials for New Drug Registration in China (2021)
Drug Evaluation Center of the State Food and Drug Administration
June 7, 2022
Relevant attachments
serial number | accessory name |
---|---|
1 | "Annual Report on Progress of Clinical Trials for New Drug Registration in China (2021. |